Estharla Madhu Rekha

Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation

Pravin Patil, Sanghratna L. Kasare, Nitin B. Haval et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 66 citations

Derivative (Chemistry), Antimicrobial Activity Evaluation, Medicine +7

Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads

Vagolu Siva Krishna, Shan Zheng, Estharla Madhu Rekha et al. · Journal of Computer-Aided Molecular Design · 2019 · 55 citations

Pulmonary Tuberculosis, Biochemistry, Medicine +8

Design, synthesis and antitubercular assessment of 1, 2, 3-triazole incorporated thiazolylcarboxylate derivatives

Rajubai D. Bakale, Shubham M. Sulakhe, Sanghratna L. Kasare et al. · Bioorganic & Medicinal Chemistry Letters · 2023 · 34 citations

Medicinal Chemistry, Antitubercular Assessment, Derivatives +7

Synthesis of isoniazid‐1,2,3‐triazole conjugates: Antitubercular, antimicrobial evaluation and molecular docking study

Adinath D. Badar, Shubham M. Sulakhe, Mahesh B. Muluk et al. · Journal of Heterocyclic Chemistry · 2020 · 31 citations

Antimicrobial Evaluation, Organic Chemistry, Antimicrobial Chemotherapy +16

Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors

Vagolu Siva Krishna, Shan Zheng, Estharla Madhu Rekha et al. · European Journal of Medicinal Chemistry · 2020 · 23 citations

Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +9